简介：中国首个获批的经导管主动脉瓣膜置换系统，其独特的支架设计使其无需球囊扩张即可工作，分段式的释放方式使得操作简便、稳定，尤其是增强的径向支撑力，适应国人主动脉瓣二瓣化比例高，钙化严重的特点。

     VenusA-Valve is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration (“NMPA”) and commercialized in China. Its unique stent design enables it to release without balloon dilatation. The co-axial release mode makes the operation simple and stable, especially the enhanced radial force, and it is more suitable for Chinese patients with high volume of calcium and bicuspid.